• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[共表达ApxIA的胸膜肺炎放线杆菌7型活疫苗株的构建与鉴定]

[Construction and characterization of Actinobacillus pleuropneumoniae serovar 7 live attenuated vaccine strain co-expressing ApxIA].

作者信息

Liu Jinlin, Chen Yan, Hu Linlin, Bei Weicheng, Chen Huanchun

机构信息

State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan 430070, China.

出版信息

Sheng Wu Gong Cheng Xue Bao. 2010 Mar;26(3):305-10.

PMID:20518341
Abstract

Actinobacillus pleuropneumoniae (A. pleuropneumoniae), the causative agent of porcine contagious pleuropneumonia (PCP), is a significant pathogen of the world pig industry, vaccination is potentially an effective tool for the prevention of PCP. The purpose of present study was to enhance the immunogenicity of A. pleuropneumoniae live vaccine strain HB04C- (serovar 7), which was unable to express ApxIA, and to develop effective multivalent vaccines for the respiratory pathogens based on the attenuated A. pleuropneumoniae. We introduced a shuttle vector containing intact apxIA gene into HB04C-, generating HB04C2, an A. pleuropneumoniae serovar 7 live attenuated vaccine strain co-expressing ApxIA. Then we investigated the biological characteristics of HB04C2. We found that the shuttle vector expressing ApxIA was stable in HB04C2, and the growth ability of HB04C2 was not affected by the shuttle vector. We observed that HB04C2 elicited detectable antibodies against ApxIA and ApxIIA when it was administrated intratracheally as a live vaccine in pigs, and all immunized pigs were protected from heterologous virulent A. pleuropneumoniae (serovar 1) challenge. In conclusion, we demonstrated that A. pleuropneumoniae live vaccine could be used as a vector for expression of heterologous antigens.

摘要

猪胸膜肺炎放线杆菌(A. pleuropneumoniae)是猪传染性胸膜肺炎(PCP)的病原体,是世界养猪业的重要病原菌,疫苗接种可能是预防PCP的有效工具。本研究的目的是增强无法表达ApxIA的猪胸膜肺炎放线杆菌活疫苗株HB04C-(血清型7)的免疫原性,并基于减毒的猪胸膜肺炎放线杆菌开发针对呼吸道病原体的有效多价疫苗。我们将含有完整apxIA基因的穿梭载体导入HB04C-,构建了HB04C2,这是一株共表达ApxIA的猪胸膜肺炎放线杆菌血清型7活疫苗株。然后我们研究了HB04C2的生物学特性。我们发现表达ApxIA的穿梭载体在HB04C2中稳定,且HB04C2的生长能力不受穿梭载体影响。我们观察到,当HB04C2作为活疫苗经气管内接种给猪时,能诱导出针对ApxIA和ApxIIA的可检测抗体,且所有免疫猪均能抵抗异源强毒猪胸膜肺炎放线杆菌(血清型1)的攻击。总之,我们证明了猪胸膜肺炎放线杆菌活疫苗可作为表达异源抗原的载体。

相似文献

1
[Construction and characterization of Actinobacillus pleuropneumoniae serovar 7 live attenuated vaccine strain co-expressing ApxIA].[共表达ApxIA的胸膜肺炎放线杆菌7型活疫苗株的构建与鉴定]
Sheng Wu Gong Cheng Xue Bao. 2010 Mar;26(3):305-10.
2
Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae.猪胸膜肺炎放线杆菌apxIA突变体的特性及免疫原性
Vet Microbiol. 2006 Dec 20;118(3-4):230-9. doi: 10.1016/j.vetmic.2006.07.013. Epub 2006 Jul 22.
3
Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.在猪中通过口服表达Apx毒素的酿酒酵母诱导针对胸膜肺炎放线杆菌攻击的保护性免疫反应。
Vet Immunol Immunopathol. 2013 Jan 15;151(1-2):132-9. doi: 10.1016/j.vetimm.2012.11.003. Epub 2012 Nov 9.
4
[Construction and immunogenicity of an attenuated mutant of Actinobacillus pleuropneumoniae by insertional inactivation of apxIC].通过插入失活 apxIC 构建胸膜肺炎放线杆菌减毒突变体及其免疫原性
Wei Sheng Wu Xue Bao. 2007 Oct;47(5):923-7.
5
Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model.ApxIA和ApxIIA DNA疫苗对鼠模型中胸膜肺炎放线杆菌致死性攻击的免疫原性和保护效力
Vaccine. 2009 Jul 23;27(34):4565-70. doi: 10.1016/j.vaccine.2009.05.058. Epub 2009 Jun 9.
6
Potential use an Actinobacillus pleuropneumoniae double mutant strain DeltaapxIICDeltaapxIVA as live vaccine that allows serological differentiation between vaccinated and infected animals.将胸膜肺炎放线杆菌双突变株DeltaapxIICDeltaapxIVA用作活疫苗的潜在用途,该疫苗可实现对已接种疫苗动物和感染动物的血清学区分。
Vaccine. 2007 Nov 1;25(44):7696-705. doi: 10.1016/j.vaccine.2007.07.053. Epub 2007 Aug 14.
7
The live attenuated Actinobacillus pleuropneumoniae triple-deletion mutant ΔapxIC ΔapxIIC ΔapxIV-ORF1 strain, SLW05, Immunizes pigs against lethal challenge with Haemophilus parasuis.胸膜肺炎放线杆菌三重缺失突变株ΔapxICΔapxIICΔapxIV-ORF1(SLW05株)减毒活疫苗可使猪对副猪嗜血杆菌的致死性攻击产生免疫。
Clin Vaccine Immunol. 2013 Feb;20(2):134-9. doi: 10.1128/CVI.00458-12. Epub 2012 Dec 5.
8
Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.一种抗胸膜肺炎放线杆菌感染的DIVA亚单位疫苗的研发。
Vaccine. 2006 Nov 30;24(49-50):7226-37. doi: 10.1016/j.vaccine.2006.06.047. Epub 2006 Jul 7.
9
Evaluation of immunogenicity and protective efficacy of Actinobacillus pleuropneumoniae HB04C(-) mutant lacking a drug resistance marker in the pigs.猪胸膜肺炎放线杆菌HB04C(-)缺失耐药标记突变株的免疫原性及保护效力评估
Vet Microbiol. 2007 Nov 15;125(1-2):120-7. doi: 10.1016/j.vetmic.2007.05.013. Epub 2007 May 21.
10
Construction of an Actinobacillus pleuropneumoniae serotype 2 prototype live negative-marker vaccine.胸膜肺炎放线杆菌2型原型活负标记疫苗的构建
Infect Immun. 2002 Dec;70(12):7120-5. doi: 10.1128/IAI.70.12.7120-7125.2002.